ACGT Corporation is a biotechnology and health care company that is focused on bringing DNA technologies to life. Founded in 1995 and headquartered in Canada, ACGT is an oligonucleotide manufacturer, providing DNA sequencing and molecular services. The company recently secured a $100.00K Seed Round investment on 12 August 2019. Despite the absence of specific details about the investors involved in this last investment round, ACGT Corporation's commitment to leveraging DNA technologies positions it in a promising space within the biotech and healthcare industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $100.00K | - | 12 Aug 2019 |
No recent news or press coverage available for ACGT Corporation.